Vytrus Biotech バランスシートの健全性
財務の健全性 基準チェック /66
Vytrus Biotech has a total shareholder equity of €6.8M and total debt of €2.0M, which brings its debt-to-equity ratio to 29.8%. Its total assets and total liabilities are €10.6M and €3.8M respectively. Vytrus Biotech's EBIT is €632.7K making its interest coverage ratio 5.5. It has cash and short-term investments of €2.2M.
主要情報
29.8%
負債資本比率
€2.03m
負債
| インタレスト・カバレッジ・レシオ | 5.5x |
| 現金 | €2.22m |
| エクイティ | €6.81m |
| 負債合計 | €3.84m |
| 総資産 | €10.64m |
財務の健全性に関する最新情報
更新なし
Recent updates
財務状況分析
短期負債: V5P's short term assets (€3.5M) exceed its short term liabilities (€1.1M).
長期負債: V5P's short term assets (€3.5M) exceed its long term liabilities (€2.8M).
デット・ツー・エクイティの歴史と分析
負債レベル: V5P has more cash than its total debt.
負債の削減: V5P's debt to equity ratio has reduced from 44.8% to 29.8% over the past 5 years.
債務返済能力: V5P's debt is well covered by operating cash flow (68.9%).
インタレストカバレッジ: V5P's interest payments on its debt are well covered by EBIT (5.5x coverage).